Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06183177
Other study ID # 2020.401
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date January 26, 2023

Study information

Verified date December 2023
Source Chinese University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Knee osteoarthritis (KOA) is a chronic progressive disease that imparts substantial socioeconomic burden to society and healthcare systems. The prevalence of KOA has dramatically risen in recent decades due to consistent increases in life expectancy, and demand for joint replacement continues to rise. Total knee replacement is indicated for end-stage KOA, as it is very effective in terms of pain relief, improvement of function, and quality of life. However, the investigators will be facing an unsustainable joint replacement burden, with significant healthcare budget and health workforce implications. To alleviate this problem, different strategies including reinforce the importance of education and exercise are included; as previous studies showed that less than 40% of patients with KOA received non-pharmacological treatment, indicating that the uptake of evidence-based guidelines in clinical practice and rehabilitation is still suboptimal. Several literatures revealed that quadriceps and hamstrings strength exercise could effectively reduce pain. It has widely accepted that patients with end stage KOA will eventually pursue total knee replacement as the only viable option, and exercise has low efficacy in reduction of pain and disability in this group of patients. So, the investigators would like to know whether exercise therapy can help severe KOA patients


Recruitment information / eligibility

Status Completed
Enrollment 517
Est. completion date January 26, 2023
Est. primary completion date January 1, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Patients with end-stage knee osteoarthritis on queue for scheduling primary total knee replacement - Completed 8-week course of physiotherapy program Exclusion Criteria: - TKR during the last 12 months - Severe heart failure or neurological diseases affecting physical functions

Study Design


Intervention

Other:
Whole-Body Vibration
10 minutes of whole-body vibration when performing semi-squatting or forward lunges (12-16 Hz, varying intensity from low to high depending on patients' tolerance
Exercise
Four to five sessions of a physiotherapist-led exercise program with education talk (20 minutes), group exercises (30 minutes) and individual exercises (30 minutes) per week supplemented with home exercises

Locations

Country Name City State
Hong Kong Michael.Ong@Cuhk.Edu.Hk Hong Kong NEW Territories

Sponsors (1)

Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Numerical pain rating scale Pain assessment. Minimum value = 0, Maximum value = 10; the higher the score the worse the pain level Baseline, 8 weeks
Primary Range of motion (ROM) of the diseased knee Measure the angle of knee bending from straight (0 degree) to fully bended (180 degrees) Baseline, 8 weeks
Primary Gait analysis Measure the movement of legs from point A to B, measure the distance in cm between steps walking on a flat surface Baseline, 8 weeks
Primary Knee Society Score Score from 0 to 100. Lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions. Baseline, 8 weeks
Primary Knee Society Functional Assessment Score from 0 to 100. Lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions. Baseline, 8 weeks
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS)-Knee pain (KP) Score from 0 to 100. 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 8 weeks
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS)-Other Symptoms (S) Score from 0 to 100. 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 8 weeks
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS)- Activities of Daily Living (ADL) Score from 0 to 100. 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 8 weeks
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS)-Sport and Recreation function Score from 0 to 100. 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 8 weeks
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS)-knee-related Quality of Life (QOL) Score from 0 to 100. 0 representing extreme knee problems and 100 representing no knee problems. Baseline, 8 weeks
Secondary Timed Up and Go test Score from 1 to 5. 1 indicates "normal function" and 5 indicates "severely abnormal function" Baseline, 8 weeks
Secondary 30-sec chair stand test Score as 3-tier categories. Below Average; Average; Above Average. Sex- and age range-specific. "Below average" indicates a high risk of falls. Baseline, 8 weeks
Secondary Functional reach test In standing, measures the distance between the length of an outstretched arm in a maximal forward reach; 10"/25 cm or greater: Low risk of falls; 6"/15cm to 10"/25cm: Risk of falling is 2x greater than normal; 6"/15cm or less: Risk of falling is 4x greater than normal; Unwilling to reach: Risk of falling is 8x greater than normal Baseline, 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A